Medical device company Globus Medical (NYSE: GMED) will be announcing earnings results this Thursday afternoon. Here’s what you need to know.
Globus Medical beat analysts’ revenue expectations last quarter, reporting revenues of $759.9 million, up 27% year on year. It was a very strong quarter for the company, with a solid beat of analysts’ full-year EPS guidance estimates and a beat of analysts’ EPS estimates.
Is Globus Medical a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Globus Medical’s revenue to grow 5% year on year, slowing from the 18.4% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Globus Medical rarely misses Wall Street’s revenue estimates.
Looking at Globus Medical’s peers in the medical devices & supplies - specialty segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Inspire Medical Systems’s revenues decreased 7.6% year on year, beating analysts’ expectations by 3%, and Integer Holdings reported a revenue decline of 2.6%, topping estimates by 3%. Inspire Medical Systems traded up 22.6% following the results while Integer Holdings was also up 3.2%.
Read our full analysis of Inspire Medical Systems’s results here and Integer Holdings’s results here.
Investors in the medical devices & supplies - specialty segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Globus Medical is up 1.1% during the same time and is heading into earnings with an average analyst price target of $103.92 (compared to the current share price of $81.39).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
